Delayed
Japan Exchange
02:00:00 2024-05-02 am EDT
|
5-day change
|
1st Jan Change
|
4,499
JPY
|
-0.24%
|
|
+0.74%
|
-0.73%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
356,525
|
404,474
|
473,445
|
347,847
|
425,016
|
526,166
|
-
|
-
|
Enterprise Value (EV)
1 |
286,286
|
323,775
|
386,950
|
258,517
|
344,144
|
444,719
|
448,371
|
450,279
|
P/E ratio
|
14.9
x
|
17.1
x
|
18.7
x
|
14.6
x
|
16.5
x
|
18.3
x
|
17.1
x
|
15.8
x
|
Yield
|
2.16%
|
1.97%
|
1.73%
|
2.39%
|
2.75%
|
2.6%
|
2.82%
|
3%
|
Capitalization / Revenue
|
0.61
x
|
0.65
x
|
0.75
x
|
0.54
x
|
0.62
x
|
0.7
x
|
0.65
x
|
0.61
x
|
EV / Revenue
|
0.49
x
|
0.52
x
|
0.61
x
|
0.4
x
|
0.5
x
|
0.59
x
|
0.55
x
|
0.52
x
|
EV / EBITDA
|
6.59
x
|
7.2
x
|
8.41
x
|
5.84
x
|
6.95
x
|
7.75
x
|
7.29
x
|
6.86
x
|
EV / FCF
|
14
x
|
15.9
x
|
29.3
x
|
23.5
x
|
38.8
x
|
79.8
x
|
45
x
|
32
x
|
FCF Yield
|
7.16%
|
6.31%
|
3.41%
|
4.26%
|
2.58%
|
1.25%
|
2.22%
|
3.13%
|
Price to Book
|
2.09
x
|
2.17
x
|
2.31
x
|
1.58
x
|
1.8
x
|
2.08
x
|
1.96
x
|
1.84
x
|
Nbr of stocks (in thousands)
|
116,894
|
116,900
|
116,900
|
116,923
|
116,923
|
116,952
|
-
|
-
|
Reference price
2 |
3,050
|
3,460
|
4,050
|
2,975
|
3,635
|
4,499
|
4,499
|
4,499
|
Announcement Date
|
5/10/19
|
5/15/20
|
5/14/21
|
5/13/22
|
5/15/23
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
588,069
|
617,769
|
634,310
|
648,734
|
690,462
|
752,189
|
809,559
|
867,710
|
EBITDA
1 |
43,475
|
44,963
|
46,008
|
44,261
|
49,520
|
57,401
|
61,518
|
65,600
|
EBIT
1 |
35,233
|
36,604
|
37,345
|
34,052
|
37,452
|
42,242
|
45,127
|
48,781
|
Operating Margin
|
5.99%
|
5.93%
|
5.89%
|
5.25%
|
5.42%
|
5.62%
|
5.57%
|
5.62%
|
Earnings before Tax (EBT)
1 |
35,071
|
34,648
|
37,188
|
34,675
|
37,710
|
42,280
|
45,620
|
49,340
|
Net income
1 |
23,933
|
23,692
|
25,329
|
23,853
|
25,703
|
28,700
|
30,814
|
33,367
|
Net margin
|
4.07%
|
3.84%
|
3.99%
|
3.68%
|
3.72%
|
3.82%
|
3.81%
|
3.85%
|
EPS
2 |
204.8
|
202.7
|
216.7
|
204.0
|
219.8
|
245.5
|
263.5
|
285.3
|
Free Cash Flow
1 |
20,503
|
20,421
|
13,187
|
11,023
|
8,868
|
5,570
|
9,962
|
14,074
|
FCF margin
|
3.49%
|
3.31%
|
2.08%
|
1.7%
|
1.28%
|
0.74%
|
1.23%
|
1.62%
|
FCF Conversion (EBITDA)
|
47.16%
|
45.42%
|
28.66%
|
24.9%
|
17.91%
|
9.7%
|
16.19%
|
21.45%
|
FCF Conversion (Net income)
|
85.67%
|
86.19%
|
52.06%
|
46.21%
|
34.5%
|
19.41%
|
32.33%
|
42.18%
|
Dividend per Share
2 |
66.00
|
68.00
|
70.00
|
71.00
|
100.0
|
116.9
|
126.7
|
135.2
|
Announcement Date
|
5/10/19
|
5/15/20
|
5/14/21
|
5/13/22
|
5/15/23
|
-
|
-
|
-
|
Fiscal Period: March |
2020 S1
|
2021 S1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
2025 Q3
|
2025 Q4
|
---|
Net sales
1 |
316,821
|
316,459
|
162,557
|
326,754
|
164,905
|
157,075
|
166,455
|
172,768
|
339,223
|
180,330
|
170,909
|
182,146
|
189,561
|
371,707
|
194,265
|
186,572
|
200,000
|
207,000
|
211,000
|
203,000
|
EBITDA
|
-
|
-
|
10,793
|
-
|
12,139
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
19,807
|
19,671
|
8,329
|
17,928
|
9,513
|
6,655
|
9,058
|
9,453
|
18,511
|
10,982
|
7,959
|
9,899
|
10,710
|
20,609
|
12,607
|
9,230
|
10,800
|
11,700
|
13,600
|
9,900
|
Operating Margin
|
6.25%
|
6.22%
|
5.12%
|
5.49%
|
5.77%
|
4.24%
|
5.44%
|
5.47%
|
5.46%
|
6.09%
|
4.66%
|
5.43%
|
5.65%
|
5.54%
|
6.49%
|
4.95%
|
5.4%
|
5.65%
|
6.45%
|
4.88%
|
Earnings before Tax (EBT)
|
19,936
|
19,564
|
-
|
18,310
|
9,618
|
-
|
9,155
|
-
|
18,513
|
11,156
|
8,041
|
10,064
|
-
|
20,594
|
12,735
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
13,532
|
13,478
|
5,654
|
12,455
|
6,549
|
4,851
|
6,298
|
6,424
|
12,722
|
7,642
|
5,339
|
6,900
|
7,154
|
14,054
|
8,727
|
5,844
|
7,600
|
8,200
|
9,500
|
6,700
|
Net margin
|
4.27%
|
4.26%
|
3.48%
|
3.81%
|
3.97%
|
3.09%
|
3.78%
|
3.72%
|
3.75%
|
4.24%
|
3.12%
|
3.79%
|
3.77%
|
3.78%
|
4.49%
|
3.13%
|
3.8%
|
3.96%
|
4.5%
|
3.3%
|
EPS
2 |
115.8
|
115.3
|
48.36
|
106.5
|
56.01
|
-
|
53.87
|
-
|
108.8
|
65.36
|
-
|
59.02
|
61.18
|
120.2
|
74.62
|
52.33
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
34.00
|
35.00
|
-
|
35.00
|
-
|
-
|
-
|
-
|
50.00
|
-
|
-
|
-
|
57.00
|
57.00
|
-
|
57.00
|
-
|
63.00
|
-
|
63.00
|
Announcement Date
|
11/8/19
|
11/11/20
|
11/12/21
|
11/12/21
|
2/14/22
|
5/13/22
|
8/12/22
|
11/14/22
|
11/14/22
|
2/14/23
|
5/15/23
|
8/10/23
|
11/14/23
|
11/14/23
|
2/14/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
70,239
|
80,699
|
86,495
|
89,330
|
80,872
|
81,447
|
77,795
|
75,887
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
20,503
|
20,421
|
13,187
|
11,023
|
8,868
|
5,570
|
9,963
|
14,074
|
ROE (net income / shareholders' equity)
|
14.7%
|
13.2%
|
12.9%
|
11.2%
|
11.3%
|
11.8%
|
11.9%
|
12%
|
ROA (Net income/ Total Assets)
|
14.1%
|
13.6%
|
12.9%
|
11%
|
11.1%
|
9.99%
|
10.1%
|
10.4%
|
Assets
1 |
170,076
|
174,211
|
196,389
|
217,065
|
231,336
|
287,328
|
303,625
|
322,153
|
Book Value Per Share
2 |
1,463
|
1,598
|
1,754
|
1,886
|
2,021
|
2,158
|
2,298
|
2,451
|
Cash Flow per Share
|
275.0
|
274.0
|
291.0
|
291.0
|
323.0
|
-
|
-
|
-
|
Capex
1 |
10,588
|
11,853
|
18,574
|
22,336
|
38,393
|
35,800
|
36,480
|
36,860
|
Capex / Sales
|
1.8%
|
1.92%
|
2.93%
|
3.44%
|
5.56%
|
4.76%
|
4.51%
|
4.25%
|
Announcement Date
|
5/10/19
|
5/15/20
|
5/14/21
|
5/13/22
|
5/15/23
|
-
|
-
|
-
|
Last Close Price
4,499
JPY Average target price
4,962
JPY Spread / Average Target +10.28% Consensus |
1st Jan change
|
Capi.
|
---|
| -0.73% | 3.35B | | -9.73% | 3.66B | | +11.98% | 2.7B | | +7.98% | 2.65B | | -9.90% | 1.71B | | +11.26% | 1.37B | | -19.60% | 971M | | -37.98% | 709M | | -0.53% | 453M | | +5.58% | 396M |
Retail - Drugs with Grocery
|